2006
DOI: 10.1016/j.ejphar.2006.08.047
|View full text |Cite
|
Sign up to set email alerts
|

The suppressant effect of GEA3162 on spontaneous serotonin release from human colonic mucosa in vitro

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2007
2007
2011
2011

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 13 publications
0
2
0
Order By: Relevance
“…Regulation of 5-HT release from the colonic mucosa may lead to new ways to control defecation or constipation in diseases such as irritable bowel syndrome (IBS). GEA3162 can suppress the 5-HT release via an action on colonic mucosa through a mechanism independent of the ODQ-sensitive cyclic GMP system or peroxynitrite generation [73].…”
Section: 234-oxatriazolium-5-aminidesmentioning
confidence: 99%
“…Regulation of 5-HT release from the colonic mucosa may lead to new ways to control defecation or constipation in diseases such as irritable bowel syndrome (IBS). GEA3162 can suppress the 5-HT release via an action on colonic mucosa through a mechanism independent of the ODQ-sensitive cyclic GMP system or peroxynitrite generation [73].…”
Section: 234-oxatriazolium-5-aminidesmentioning
confidence: 99%
“…Kojima et al [46] demonstrated that a lipophilic nitric oxide (NO)-releasing compound 5-amino-3-(3, 4-dichlorophenyl) 1,2,3,4-oxatriazolium (GEA3162) can suppress 5-HT release from colonic mucosa through a mechanism that does not involve cyclic GMP system or peroxynitrite generation. The effects of this agent on 5-HT secretion in response to infection have not been reported to date.…”
Section: Novel Treatment Strategies Targeting Enteroendocrine and Neumentioning
confidence: 99%